4888 STELLA PHARMA CORPORATIONステラファーマTSE Growth / Pharmaceuticals
0 posts
STELLA PHARMA CORPORATION stock plunged on Nov 20: what happened
It closed at ¥391 on Nov 20 (−¥68.0, −14.81%), ranking #12 among the top losers of all stocks on the Tokyo Stock Exchange.
No disclosures were found for this stock around that day. Share what you know in the posts below.
Changes are calculated from the closing prices this site collects daily; limit-up/down is an estimate based on the daily price limit. Please make your own investment decisions.
STELLA PHARMA CORPORATION (4888) at a glance
Prices are from Yahoo! Finance and may be delayed. Always check the latest price before trading.
STELLA PHARMA CORPORATION (4888) Stock Price History
STELLA PHARMA CORPORATION closed at ¥391 on Nov 20, 2026, −6.7% over 1 month, +53.9% over 1 year.
If you had invested ¥100,000 1 month ago, it would be worth ¥93,317 today (−6.7%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved −11.9%, while this stock moved −6.7%.
Last 10 Trading Days
| Date | Close | Change | % Change |
|---|---|---|---|
| Nov 20 (Fri) | ¥391 | −68 | −14.81% |
| Nov 19 (Thu) | ¥459 | −1 | −0.22% |
| Nov 18 (Wed) | ¥460 | +28 | +6.48% |
| Nov 17 (Tue) | ¥432 | +80 | +22.73% |
| Nov 16 (Mon) | ¥352 | −3 | −0.85% |
| Nov 13 (Fri) | ¥355 | −3 | −0.84% |
| Nov 12 (Thu) | ¥358 | −18 | −4.79% |
| Nov 11 (Wed) | ¥376 | +8 | +2.17% |
| Nov 10 (Tue) | ¥368 | +18 | +5.14% |
| Nov 9 (Mon) | ¥350 | +5 | +1.45% |
If you had invested ¥100,000 3 months ago, it would be worth ¥111,714 today (+11.7%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved −14.8%, while this stock moved +11.7%.
Last 10 Trading Days
| Date | Close | Change | % Change |
|---|---|---|---|
| Nov 20 (Fri) | ¥391 | −68 | −14.81% |
| Nov 19 (Thu) | ¥459 | −1 | −0.22% |
| Nov 18 (Wed) | ¥460 | +28 | +6.48% |
| Nov 17 (Tue) | ¥432 | +80 | +22.73% |
| Nov 16 (Mon) | ¥352 | −3 | −0.85% |
| Nov 13 (Fri) | ¥355 | −3 | −0.84% |
| Nov 12 (Thu) | ¥358 | −18 | −4.79% |
| Nov 11 (Wed) | ¥376 | +8 | +2.17% |
| Nov 10 (Tue) | ¥368 | +18 | +5.14% |
| Nov 9 (Mon) | ¥350 | +5 | +1.45% |
If you had invested ¥100,000 6 months ago, it would be worth ¥94,903 today (−5.1%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved −5.6%, while this stock moved −5.1%.
Monthly Closes
| Month | Month-End Close | Monthly % |
|---|---|---|
| Nov 2026 | ¥391 | −4.9% |
| Oct 2026 | ¥411 | −4.9% |
| Sep 2026 | ¥432 | +20.0% |
| Aug 2026 | ¥360 | +17.3% |
| Jul 2026 | ¥307 | −1.3% |
| Jun 2026 | ¥311 | −12.9% |
| May 2026 | ¥357 | −30.5% |
If you had invested ¥100,000 1 year ago, it would be worth ¥153,937 today (+53.9%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +13.3%, while this stock moved +53.9%.
Monthly Closes
| Month | Month-End Close | Monthly % |
|---|---|---|
| Nov 2026 | ¥391 | −4.9% |
| Oct 2026 | ¥411 | −4.9% |
| Sep 2026 | ¥432 | +20.0% |
| Aug 2026 | ¥360 | +17.3% |
| Jul 2026 | ¥307 | −1.3% |
| Jun 2026 | ¥311 | −12.9% |
| May 2026 | ¥357 | −30.5% |
| Apr 2026 | ¥514 | −32.3% |
| Mar 2026 | ¥759 | +65.7% |
| Feb 2026 | ¥458 | +47.7% |
| Jan 2026 | ¥310 | +52.7% |
| Dec 2025 | ¥203 | −22.2% |
| Nov 2025 | ¥261 | ― |
If you had invested ¥100,000 3 years ago, it would be worth ¥124,127 today (+24.1%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +67.8%, while this stock moved +24.1%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | ¥391 | +92.6% |
| 2025 | ¥203 | ― |
If you had invested ¥100,000 5 years ago, it would be worth ¥66,159 today (−33.8%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +96.3%, while this stock moved −33.8%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | ¥391 | +92.6% |
| 2025 | ¥203 | ― |
If you had invested ¥100,000 in Apr 2021, it would be worth ¥54,230 today (−45.8%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +96.0%, while this stock moved −45.8%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | ¥391 | +92.6% |
| 2025 | ¥203 | −62.2% |
| 2024 | ¥537 | +88.4% |
| 2023 | ¥285 | −28.8% |
| 2022 | ¥400 | −56.5% |
| 2021 | ¥920 | ― |
Daily, weekly and monthly closes (Yahoo! Finance, split-adjusted, dividends excluded). "All" covers the range Yahoo provides (from Apr 2021). Please check the latest prices before trading.
STELLA PHARMA CORPORATION (4888) financial indicators
PER, ROE and dividend yield are based on company forecasts, calculated from earnings reports and the closing price after each trading day.
Key features of STELLA PHARMA CORPORATION (4888)
Business overview
The company researches and develops boron drugs for BNCT (boron neutron capture therapy), a form of cancer radiation therapy. BNCT selectively destroys cancer cells by irradiating boron that has accumulated in them with thermal neutrons. In March 2020 it obtained approval for "Steboronine" for head and neck cancer, and it continues research with accelerator makers to expand its uses.
Summarized from the annual securities report (fiscal year ended March 2026) filed on EDINET.
Position within Pharmaceuticals (79 companies)
| PBR | 4.43x | Above the sector median of 1.86x (No. 65 from the lowest) |
|---|---|---|
| ROE | -19.38% | No. 41 in the sector (highest first); median 4.17% |
| Market cap | ¥14.5 bn | No. 42 in the sector (largest first) |
Ranks among stocks in the same Tokyo Stock Exchange sector (33 sectors). PER and PBR of zero or below (losses, negative equity) are excluded and ranked from the lowest.
Price milestones
| 52-week high | ¥881 | 3/27 |
|---|---|---|
| 52-week low | ¥203 | 2025/12/30 |
| Current position | 27.7% | Where the low is 0% and the high is 100% (close on 11/20: ¥391) |
| Year to date | +92.6% | No. 3 of 77 in the sector (best first) |
| 1 year | +53.9% |
Based on closing prices (adjusted for stock splits, excluding dividends).
Kabutaro's ranking history
| Top 50 gainers | 3 times | Latest: 11/18 (No. 40) |
|---|---|---|
| Top 50 losers | 3 times | Latest: 11/20 (No. 12) |
Gainers and losers have been recorded since 9/2026.
Calculated as of 2026/11/20 17:30 JST. Updated every business day in the evening.
Recent disclosures (TDnet, in Japanese)
- 11/17 09:002027年3月期 第2四半期決算説明会資料
- 11/16 15:00皮膚血管肉腫を対象としたステボロニンの薬事審議会における審議予定に関するお知らせ
- 11/16 09:30再発髄膜腫を対象としたステボロニンの製造販売承認事項一部変更承認取得のお知らせ~本邦で初めて「再発髄膜腫」を効能又は効果とする医薬品として承認~
- 11/13 15:30営業外収益(補助金収入)の計上に関するお知らせ
- 11/13 15:302027年3月期 第2四半期(中間期)決算短信〔日本基準〕(非連結)
- 11/04 15:30株式及び新株予約権発行プログラム設定契約に基づく第4回第三者割当による新株式及び新株予約権の払込完了のお知らせ
- 10/22 08:00再発髄膜腫を対象としたステボロニンの薬事審議会における審議結果に関するお知らせ
- 10/19 15:30株式及び新株予約権発行プログラム設定契約に基づく第4回第三者割当による新株式及び新株予約権の発行に関するお知らせ
- 10/07 15:30再発髄膜腫を対象としたステボロニンの薬事審議会における審議予定に関するお知らせ
- 10/01 11:00深部がんに対する18F-FBPAの取り込み能に関する研究者主導臨床研究の実施契約締結について
Filings from the past 12 months (10).
Posts
This board is shared with the Japanese and Chinese versions. Feel free to write in English, Chinese or Japanese.
No posts yet. Be the first to write something.
Write on the STELLA PHARMA CORPORATION board
More Japanese stocks in English
- Renascience Inc.4889
- iShares Yen Appreciation Focus ETF488A
- Tsubota Laboratory Incorporated4890
- TMS Co.,Ltd.4891
- Cyfuse Biomedical K.K.4892
- Noile-Immune Biotech Inc.4893
- Cuorips Inc.4894
- K Pharma,Inc.4896
- TSE REIT Logistics Focus ETF489A
- KONICA MINOLTA,INC.4902
- SENSE TRUST Co.,Ltd.490A
- Lion Corporation4912